Neurofibromatosis 2 News and Research

RSS
Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

Study finds potential new therapeutic targets for childhood brain tumors

Study finds potential new therapeutic targets for childhood brain tumors

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Mapping genetic links between diseases using data from electronic health records

Mapping genetic links between diseases using data from electronic health records

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Researchers uncover novel molecular clues for tumor aggression in neurofibromatosis type 1

Researchers uncover novel molecular clues for tumor aggression in neurofibromatosis type 1

New grants support research on mechanics of tumor cells

New grants support research on mechanics of tumor cells

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Researchers open up possible avenue for new cancer treatments without side effects

Researchers open up possible avenue for new cancer treatments without side effects

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Children's Tumor Foundation establishes significant research initiative to combat NF2

Children's Tumor Foundation establishes significant research initiative to combat NF2

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Research into cancer signaling network reveals new roadmap to tumor control

Research into cancer signaling network reveals new roadmap to tumor control

Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1

Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1

Mice sleeping fitfully help unravel mystery of insomnia

Mice sleeping fitfully help unravel mystery of insomnia

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.